Aerovate Therapeutics Stock Price History

If you're considering investing in Aerovate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Aerovate Therapeutics stands at 2.58, as last reported on the 18th of January 2025, with the highest price reaching 2.60 and the lowest price hitting 2.44 during the day. Aerovate Therapeutics appears to be risky, given 3 months investment horizon. Aerovate Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0643, which signifies that the company had a 0.0643% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Aerovate Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Aerovate Therapeutics' Risk Adjusted Performance of 0.0899, downside deviation of 2.25, and Mean Deviation of 2.22 to double-check if our risk estimates are consistent with your expectations. At present, Aerovate Therapeutics' Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 14.4 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 27.3 M. . At present, Aerovate Therapeutics' Price To Book Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Fair Value is expected to grow to 5.14, whereas Price Earnings To Growth Ratio is forecasted to decline to (0.20). Aerovate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0643

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns		AVTE
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

Expected Return

Risk-Adjusted Return